Product Information(Japanese)
Contact Us
for Business Opportunity
2013.05.14
Summary of Financial Results For the First Quarter of Fiscal Year Ending December 31, 2013[Japanese GAAP](Non-consolidated)
2013.05.10
Onconova Completes Enrollment in ONTIME Pivotal Phase 3 Study of Rigosertib in Patients with High-risk Myelodysplastic Syndromes
2013.05.08
SymBio Initiates Japanese Phase II Trial for TREAKISYM® (Bendamustine) in CLL
2013.05.07
JCO (Journal of Clinical Oncology)- Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Product Information(Japanese)
Contact Us